covid study mandates



 uuhscclinicalfinal.png        uuhsccovidfinal.png        cdcinfoprovfinal.png


irbfinal.png        vice_presfinal.png        dopsfinal.png


visitor_guidelinesfinal.png        partipant_screeningfinal.png


COVID-19 is a pandemic turning our world upside down. Utah CCTS wants to halt the effects of this virus and the first step is to conduct research. Researchers and future research volunteers can find resources at the Office of Research Participant Advocacy.


View the COVID-19 research REDCap survey report



Listen to Dr. Emily Spivak discuss COVID-19 on KSL News Radio's Coronavirus Q&A

Watch Dr. Rachel Hess' FB Live interview with Silicon Slopes about the hydroxychloroquine trials

University of Utah Health and Intermountain Healthcare Launch COVID-19 Launch Trials

U Study on Hydroxychloroquine Still on After Reports Dismiss its Effectiveness

University of Utah Researchers Studying Hydroxychloroquine to Stem COVID-19 Spread

U of U, Intermountain Researchers Launch Study of Malaria Drug’s Use in Coronavirus Cases

COVID-19 Patients at University Hospital Getting Remdesivir as Part of Global Trial

University of Utah Doctors Treating COVID-19 Patients in Remdesivir Trial 






What is the Center for Clinical and Translational Science (CCTS)?

The CCTS is the home for clinical and translational science in our institutions, the state of Utah, and within the Mountain West Region. It builds on our strengths in genetics and bioinformatics to translate promising bench science into practices that improve human health.

The center serves as an academic home for clinical and translational research, developing innovative health services for the community and health researchers, and training a new generation of clinical and translational investigators. Four foundations of discovery compose the center: Clinical Trials Support, Population Health, Precision Medicine, and Workforce Development, and these foundations provide support for T1 to T4 research.








FOA Publication Date: January 21, 2020
Earliest Submission: February 24, 2020
Submission Deadline:
March 24, 2020

The National Center for Advancing Translational Science (NCATS) is again collaborating on a trans-NIH initiative.  A re-issuance of the funding opportunity announcement RFA-NS-19-021 was recently published to solicit applications for clinical trial planning and implementation to generate evidence-based pain management best practices for the use of existing medications or devices for specific pain conditions.

RFA-NS-20-028 is the funding announcement for the HEAL Initiative: Pain Management Effectiveness Research Network: Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) and is prioritizing the following areas of interest to generate evidence-based pain management best practices for the use of existing medications or devices for specific pain conditions. The guidelines should be of use to providers in primary care, emergency departments, dental clinics, and hospital settings. The pain conditions of high priority are:

  • pain management in emergency departments, dental clinics, primary care and hospitals;
  • chronic overlapping pain conditions;
  • best practices for effective analgesics when appropriate;
  • pain management in individuals at risk of or with OUD;
  • pain management in those with co-occurring mental health disorders; and
  • Non cancer pain management in persons with medical comorbidities

For more information, please contact

Latest News

More News
May 15, 2020

CCTS Community Engagement Team Adapts to Accommodate Social Distancing

The CCTS Community Collaboration and Engagement Team supports researchers’ engagement and collaboration with community members, patients, and other stakeholders. To address the need for social distancing due to COVID-19, the Team has successfully moved our Engagement Studios and Community Advisory Boards - formerly held in-person - to Zoom. This has enabled research to move forward in spite of the pandemic. ... Read More

University of Utah Health and Intermountain Healthcare Launch COVID-19 Clinical Trials
Apr 08, 2020

University of Utah Health and Intermountain Healthcare Launch COVID-19 Clinical Trials

research news, covid-19, coronavirus, iii, hydroxychloroquine, clinical trial

Researchers from University of Utah Health and Intermountain Healthcare in Salt Lake City have launched two vital clinical trials to test the effectiveness and safety of two drugs – hydroxychloroquine (HCQ) and azithromycin – to treat patients with COVID-19 (infection with the novel coronavirus).... Read More

Internal Medicine,Population Health Sciences
Dec 18, 2019

uTRAC Clinical Research Accrual Tracking Module

Beginning in January 2020, clinical research teams will begin reporting accrual data in uTRAC. This will apply to all IRB approved projects that meet the NIH definition of a clinical trial regardless of funding source (see weblink further below to determine if your study is applicable). Study teams from Pediatrics and Internal Medicine have successfully piloted this system over the last year. Early adoption is encouraged. ... Read More


                 PLEASE CITE THE CCTS!

View citing instructions

REDCap Support


What Is Clinical Research?

NIH HEAL Initiative (Helping to End Addiction Long Term)

To speed scientific solutions for the national opioid public health crisis, focusing on pain management and treatment for opioid misuse and addiction.
Interested in pain or opioid research? Join our Directory of Experts

Upcoming Events

View Calendar

Center News

Trial Innovation Network